Circulating Ki-67 Index in Plasma as a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2010.03.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia

Research in Molecular Medicine (RMM)
2019English

Prognostic Importance of Ki-67 Labeling Index in Grade II Glial Tumors

Turk Onkoloji Dergisi
Oncology
2018English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

Pathologia
2014English

Chronic Lymphocytic Leukemia in Pregnancy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

IDH1/2 Mutation Status Combined With Ki-67 Labeling Index Defines Distinct Prognostic Groups in Glioma

Oncotarget
Oncology
2015English

Chronic Lymphocytic Leukemia and Prognostic Models: A Bridge Between Clinical and Biological Markers

American Journal of Hematology
Hematology
2017English

Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

Clinical Cancer Research
Cancer ResearchOncology
2006English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy